FDA investigators discovered more quality issues at an Intas Pharmaceuticals factory in Ahmedabad, India, which halted some production after a November inspection found a truck full of shredded documents, Bloomberg reported June 15. In May, the FDA inspected the facility and investigators said they could not ensure the “safety, efficacy, purity and overall quality of […]